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Background:  The  best  options  of internal  ﬁxation  for  unstable  intertrochanteric  fractures  in  elderly  Chi-
nese patients  remain  controversial.  The  Asia  proximal  femoral  nail antirotation  (PFNA-II)  was  speciﬁcally
designed  for Asian  patients,  which  could  be  more  effective  than  the  regular  proximal  femoral  nail antiro-
tation  (PFNA).  Compared  to PFNA,  whether  PFNA-II  is  associated  with  shorter  operative  time  and  lower
rates  of complications  is unknown.
Hypothesis:  The  rate  of  complications  using  PFNA-II  is lower  than  PFNA  for the  treatment  of  unstable
intertrochanteric  fractures  in elderly  Chinese  patients,  and  the  operation  using  PFNA-II  is quicker.
Materials  and  methods:  Between  June  2008  and  December  2011,  188  patients  with  unstable
intertrochanteric  fractures  treated  with  the  PFNA-II  (n = 118)  or  PFNA  (n = 70)  were  retrospectively  eval-
uated.  Follow-up  evaluations  were  performed  at  1, 3, 6, 9 and 12  months,  and  every year  thereafter.
According  to residual  valgus-varus  deformation,  the  quality  of  the  fracture  reduction  was  graded  as  poor
(>10◦ deformation),  acceptable  (5◦ to  10◦ deformation),  or good  (<5◦ deformation).  The operative  time,
intraoperative  blood  loss,  overall  time  of  ﬂuoroscopy,  blood  transfusion  volume,  postoperative  drainage,
length  of  hospital  stay  and  postoperative  complications  were  recorded.
Results:  The  mean  operative  time  in  the PFNA-II  group  was  signiﬁcantly  shorter  than  that  in the
PFNA  group  (66.25  ± 13.15  vs  79.50  ±  21.12  minutes;  P < 0.05),  intraoperative  blood  loss  was  smaller
(131.86  ±  69.16  vs  162.14  ±  66.18  mL;  P < 0.05),  and  fewer  local  complications  were  observed  (25%  vs
46%;  P <  0.05).  There  was  no  signiﬁcant  difference  in the  postoperative  blood  transfusions,  overall  time
of  ﬂuoroscopy,  postoperative  drainage,  length  of  hospital  stay,  fracture  reduction,  the  position  of the
implant  and  tip apex  distance  between  the  two  groups.  At follow-up,  no  signiﬁcant  difference  was  found
between  the  two groups  in Harris  hip  score  (HHS)  (86.19  ±  6.53  vs  85.27  ± 5.47;  P >  0.05),  visual  analogue
scale  (VAS)  (0.87  ±  0.85  vs  0.97  ± 0.87;  P  > 0.05).
Discussion:  Due to its  special  design  for  the Asian  population,  PFNA-II  offers  a better  match  with  the
Chinese  people’s  proximal  femur  anatomic  structure.  This  study  showed  that the  rate  of  complications
using  PFNA-II  is lower  than  PFNA  for  the treatment  of  unstable  intertrochanteric  fractures  in elderly
Chinese  patients,  and  the operation  time  is  shorter.
Level of evidence:  Level  III, case  control  study.
©  2015  Elsevier  Masson  SAS.  All  rights  reserved.. IntroductionIntertrochanteric fractures are relatively common among
he elderly, 90% of such fractures occurring in persons aged
ver 65 years [1]. Most elderly patients with intertrochanteric
∗ Corresponding author.
E-mail address: jingjuehuapaper@163.com (J. Jing).
1 Jun Li and Li Cheng contributed equally to this work.
http://dx.doi.org/10.1016/j.otsr.2014.12.011
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.fractures have osteoporosis [2]. This type of geriatric fracture
has a relatively high mortality and causes severe impairment
of function [3]. Common treatment options for Chinese patients
include intramedullary nailing with either the proximal femoral
nail antirotation or Asia proximal femoral nail antirotation, both
of which represent the most commonly used implants for the
treatment of unstable intertrochanteric fractures [4–8].
The proximal femoral nail antirotation (PFNA) was used in clinic
for the ﬁrst time in 2004. It is an original intramedullary device
which contain a helical blade inserted by impaction to result in bone
1 gy: Surgery & Research 101 (2015) 143–146
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ompaction around the blade to retard rotation and varus collapse
9]. Several studies showed few complications and positive results
ith PFNA for unstable intertrochanteric fractures [10–12]. How-
ver, the proximal end of the nail was not matched with the speciﬁc
natomy of some short elderly patients. Further modiﬁcations of
he nail are necessary for the elderly Chinese population, intra- and
ostoperative complications, such as difﬁculty inserting it, pain in
he hip and thigh, lateral blade migration, femoral shaft fracture,
nd lateral cortex splitting intraoperatively, have been reported
ince it began being used in Asian patients [4,13]. In response to
hese concerns, AO/ASIF developed the Asia proximal femoral nail
ntirotation (PFNA-II) speciﬁcally for Asian patients. Although both
ails have been reported to have good clinical outcomes, no study
as compared the outcomes of the PFNA and PFNA-II. Therefore, we
onducted a case control study to assess if the PFNA-II was associ-
ted with shorter operative time and lower rates of complications.
e hypothesized that the rate of complications using PFNA-II is
ower than PFNA for the treatment of unstable intertrochanteric
ractures in elderly Chinese patients, and the operation using PFNA-
I is quicker.
. Patients and methods
.1. Patients
From June 2008 to December 2011, all patients with unstable
ntertrochanteric fractures were treated with a PFNA or a PFNA-II
Synthes GmbH, Oberdorf, Switzerland) in our hospital. The study
as approved by the Ethics Committee of The Second Hospital of
nhui Medical University. All patients have provided their written
nformed consent to participate in this study. We  did not conduct
ur clinical investigations outside of our country of residence.
The PFNA or PFNA-II was chosen according to surgeon prefer-
nce and availability of the device. Patients eligible for the study
ere at least 60 years of age. Exclusion criteria included patholog-
cal intertrochanteric fractures, open fractures, multiple fractures,
resence of degenerative osteoarthritis/arthritis in the injured hip
nd severe concomitant medical condition (grade V on the Ameri-
an Society of Anesthesiologists [ASA] scale) [14]. All the patients’
ecords, including gender, age, body mass index (BMI), ASA class
ating and fracture type according to AO/OTA classiﬁcation, were
omplete.
.2. Surgery and rehabilitation
Surgery was carried out under general anaesthesia. A fracture
able and image intensiﬁer were used in all cases. The PFNA was
nserted without diaphyseal reaming, which was a solid titanium
ail 170, 200 or 240 mm in length and 10 or 11 mm in diameter. The
elical blade which attached to a particular inserter was introduced
ver the guide wire with hammer. While the introduction was ﬁn-
shed, the helical blade could be ﬁxed to prevent rotation. The PFNA
ould be distally ﬁxed either statically or dynamically. Somewhat
ifferently, the PFNA-II nail used in the study is a solid titanium nail
hat is 170 or 200 mm long and 9, 10, or 11 mm in diameter. The
urgical procedure was the same as the one used for the standard
FNA [6,10].
Postoperatively, analgesic care and diet were related to local
tandards and equal for both groups. Antithrombotic prophylaxis
as administered using low-molecular-weight heparin (Lovenox
0 mg)  for 3–5 days, and all patients received prophylactic antibi-
tics (Cefotiam 4.0 g) for 3 days. As the importance of rehabilitation,
atients were encouraged to move the hip, knee and ankle joints on
he ﬁrst postoperative day and partial weight bearing was  allowed
ith the aid of crutches on the following day.Fig. 1. A: anteroposterior hip radiographs of intertrochanteric fracture treated with
PFNA. B: anteroposterior hip radiographs of intertrochanteric fracture treated with
PFNA-II.
2.3. Method of assessment
Follow-up evaluations were performed at 1, 3, 6, 9 and 12
months, and every year thereafter. The operative time, blood loss
during surgery, amount of transfused blood, overall ﬂuoroscopy
time, postoperation drainage, duration of hospitalization, postop-
erative complications, and assessment of nail handling for Asia
proximal femoral nail antirotation were compared with those of
proximal femoral nail antirotation.
Plain anteroposterior and lateral radiographs were obtained at
each visit (Fig. 1). At the last follow-up, the degree of pain was
measured by visual analogue scale (VAS) and the functional out-
come was evaluated on the basis of Harris Hip Score (HHS) [15]. The
radiographs of affected hip were achieved in the AP. The mediolat-
eral planes at every follow-up visit, the extent of fracture and any
changes in the position of the implant were noted.
The quality of the fracture reduction was graded as poor
(>10◦ varus/valgus), acceptable (5◦–10◦ varus/valgus), or good (<5◦
varus/valgus). The position of the implant was  graded as optimal if
the blade was  placed into the centre of the neck on a lateral view
and lower half on a AP view [6]. Which was graded as suboptimal
if the blade was  not placed into the centre of the neck on a lateral
view or lower half on a AP view.
2.4. Statistical analysis
Statistical analysis was  performed using SPSS statistical
package, version 16.0 (SPSS Inc., Chicago, IL, USA) for Windows.
Quantitative variables were analysed using the Student’s t-test and
categorical variables were analysed by the 2 test or Fisher’s exact
test where appropriate. The level of statistical signiﬁcance was set
at a two-sided P-value of 0.05.3. Results
Between June 2008 and December 2011, 188 elderly Chinese
patients with unstable intertrochanteric fractures were treated
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Table  1
Patient demographics.
PFNA-II PFNA P
Man: woman 52:66 32:38 0.88
Age  (y) 67.42 ± 16.40
(60–98)
66.31 ± 16.44
(60–88)
0.655
BMI  22.49 ± 3.88
(13.89–34.65)
22.94 ± 3.56
(16.69–34.19)
0.425
Side (left/right) 58:60 34:36 0.939
Injury mechanism 0.779
Fall  at home 82 50
Trafﬁc accident 36 20
AO type of fracture 0.446
31A2 98 55
31A3 20 15
ASA classiﬁcation 0.456
ASA  1 15 14
ASA 2 48 26
ASA 3 45 22
ASA 4 10 8
Follow-up (months) 29.08 ± 9.07
(12–36)
29.49 ± 9.29
(12–36)
0.772
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Table 3
Postoperative complications.
PFNA-II PFNA P-value
Systemic complications 28 19 0.728
Pneumonia 3 3 0.819
Cardiovascular disorder 4 2 1
Urinary tract infection 5 3 1
Hypoproteinemia 10 6 1
Deep vein thrombosis 1 1 1
Pressure sore 5 4 0.916
Local complications 29 32 0.004
Superﬁcial infection 2 1 1
Deep infection 1 1 1
Fat  liquefaction 8 5 1
Haematoma 10 5 0.745
Cutout 0 2 0.267
Thigh pain 8 18 0
PFNA-II: Asia proximal femoral nail antirotation; PFNA: proximal femoral nail
antirotation.
Table 4
Outcome of follow-up according to Harris and visual analogue scale.
PFNA-II PFNA P-value
HHS 86.19 ± 6.53 (58–93) 85.27 ± 5.47 (66–93) 0.326
VAS 0.87 ± 0.85 (0–3) 0.97 ± 0.87 (0–3) 0.448
Mortality (%) 7 6 0.557
T
O
PFNA-II: Asia proximal femoral nail antirotation; PFNA: proximal femoral nail
ntirotation; BMI: body mass index; ASA: American Society of Anesthesiologists.
ith PFNA (n = 70) or PFNA-II (n = 118). No signiﬁcant differences
ere found between the two groups in gender, age, BMI, side of
racture, type of fracture, ASA score and follow-up time (Table 1).
The mean surgical time in the PFNA-II group was 66 min  and was
igniﬁcantly shorter than that in the PFNA group, in which the mean
ime was 79 min  (P < 0.05) (Table 2). Blood loss was signiﬁcantly less
han in the PFNA-II group than that in the PFNA group (P < 0.05).
here was no signiﬁcant difference in amount of transfused blood,
verall ﬂuoroscopy time, postoperation drainage and duration of
ospitalization between the two groups (P > 0.05) (Table 2).
Fracture reduction was considered good or acceptable in 181
atients (113 in the PFNA-II group, 68 in the PFNA group) on post-
perative radiographs. The position of the implant was optimal in
55 patients (102 in the PFNA-II group, 53 in the PFNA group). The
ean tip apex distance was 19.25 mm in the PFNA-II group and
9.04 mm in the PFNA group. There was no signiﬁcant difference
etween the two groups in fracture reduction, the position of the
mplant and tip apex distance (P > 0.05) (Table 2).
In our study, six main postoperative systemic complications
ccurred, including pneumonia, cardiovascular disorder, urinary
ract infection, hypoproteinemia, deep vein thrombosis and pres-
ure sore. No signiﬁcant difference was found between the two
roups in systemic complications. Two cutouts occurred in the
FNA group, but none occurred in the PFNA-II group. Several
atients reported thigh pain during the follow-up period: 8 patients
n the PFNA-II group and 18 in the PFNA group (P < 0.05). In the
able 2
perative records of patients.
PFNA-II 
Operation time (min) 66.25 ± 13.15 (43–128) 
Blood loss (mL) 131.86 ± 69.16 (30–300) 
Blood transfusion (U) 2.37 ± 0.88 (1–4) 
Fluoroscopy time (s) 87.36 ± 21.80 (25–200) 
Postoperation drainage (mL) 68.56 ± 26.34 (20–200) 
Hospitalization duration (d) 10.81 ± 3.28 (6–16) 
Fracture reduction 
Good  93 
Acceptable 20 
Poor 5 
The position of implant
Optimal 102 
Suboptimal 16 
Tip  apex distance (mm)  19.25 ± 4.71 (9–36) 
FNA-II: Asia proximal femoral nail antirotation; PFNA: proximal femoral nail antirotatioPFNA-II: Asia proximal femoral nail antirotation; PFNA: proximal femoral nail
antirotation; HHS: Harris Hip Score; VAS: visual analogue scale.
PFNA-II group, fewer local complications were observed (P < 0.05)
(Table 3).
The mean HHS was 86.19 in the PFNA-II group and 85.27 in the
PFNA group, and the mean VAS was 0.87 in the former and 0.97
in the latter group. The mortality rate at one year was 7% in the
PFNA-II group, compared with 6% in the PFNA group. No signiﬁcant
difference was found between the two groups in HHS, VAS and the
one-year mortality rate (P > 0.05) (Table 4).
4. Discussion
In the present study, we compared PFNA and PFNA-II for the
treatment of unstable intertrochanteric fractures in elderly Chi-
nese patients. Our results suggested that the rate of complications
using PFNA-II was  lower than PFNA for the treatment of unsta-
ble intertrochanteric fractures in elderly Chinese patients, and the
operation time was shorter.A weakness of this study is that the operations were performed
by different surgeons, however, a single observer collected data
and the surgical procedure was the same. The study design was a
PFNA P-value
79.50 ± 21.12 (49–142) 0
162.14 ± 66.18 (100–350) 0.004
2.75 ± 0.87 (1–4) 0.221
87.64 ± 13.41 (60–121) 0.921
71.34 ± 21.61 (30–150) 0.456
10.30 ± 2.56 (6–15) 0.234
0.775
58
10
2
0.075
53
17
19.04 ± 4.70 (10–31) 0.766
n.
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etrospective design; the two groups were comparable according
o major variables (gender, age, BMI, side of fracture, type of
racture, ASA score and follow-up time). However, a randomized,
rospective study is needed in the future to further conﬁrm the
urrent ﬁndings.
Intertrochanteric fractures is one among the most common
njuries in the elderly population, and patients’ quality of life is
ffected signiﬁcantly [16–19]. The goal of treating these osteo-
orotic fractures is the same as for other hip fractures: to decrease
ain and to restore the patient’s walking ability to the pre-injury
evel [20,21]. The treatment of unstable intertrochanteric fractures
emains challenging to orthopedic surgeons, because of old age
nd poor bone quality [22–24]. Moreover, the ideal treatment for
nstable intertrochanteric fractures in elderly patients remains
ontroversial [25–27]. The proximal femoral nailing (PFN) has been
idely used in the unstable intertrochanteric fractures [28]. The
O/ASIF group further modiﬁed PFN to the PFNA to ameliorate the
ngular and rotational stability with one single element. It is an
ntramedullary device with a helical blade rather than a screw for
etter purchase in the femoral head and was tested in a clinical
tudy [10]. Because of the height in Asian population on average is
ess than that of Americans or Europeans, the femoral neck diam-
ter and proximal femoral length are relatively shorter [29]. The
tandard proximal femoral nail antirotation nail has a mediolateral
ngle of 6◦ and a proximal diameter of 17 mm.  To insert the nail, a
uch larger femoral canal needs to be prepared to accommodate
he nail of the given diameter [30]. This means that a mass of corti-
al bone has to be reamed, thus weakening the osteoporotic bone in
ost patients. The study shows that the necessary over reaming of
he shaft weakens the entire shaft, and that reaming of the medulla
an result in increased blood loss [31,32]. Moreover, this geomet-
ic mismatch between the proximal end of the nail and proximal
emur is the most probable cause of the intraoperative complica-
ions of jamming and fracturing of the lateral cortex. The PFNA-II
as designed to avoid these problems, which was designed to have
 mediolateral angle of 5◦ and a proximal diameter of 16.5 mm.  The
odiﬁed nail has a considerably better anatomic ﬁt. This effectively
ecreases the hoop stress inside the femoral shaft and may  have
ed to a signiﬁcant decrease in intraoperative and postoperative
iaphyseal fractures [33].
Unstable intertrochanteric fractures were treated successfully
ith the PFNA or PFNA-II in elderly Chinese patients. However,
FNA-II is superior to PFNA in terms of surgical time, intraopera-
ive blood loss, and postoperative complications in elderly Chinese
atients. Further study is needed to conﬁrm these early results.
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